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Since the first attempts to use standardised methods
for sampling induced airways sputum, two methods
for processing the expectorate have evolved. The first
involves selecting all viscid or denser portions from
the expectorated sample with the aid of an inverted
microscope [1, 2]. This method has been extensively
evaluated and reported in detail [2–4]. The second
approach involves processing the entire expectorate,
comprising sputum plus variable amounts of saliva
[5]. Recent modifications to this method include
collecting saliva and sputum separately in order to
reduce salivary contamination [6–8]. Both methods
have advantages and disadvantages.
The advantages of using selected sputum are:
squamous cell contamination is v5%, making cell
counting easier and quicker to perform, the total cell
count (TCC) can be expressed per gram of lower
airway secretions, and concentrations of chemicals in
the fluid phase are unaffected by the confounding
influence of saliva, and can be accurately corrected
for dilution. The disadvantage is that selection takes
a few minutes longer to perform and requires an
inverted microscope. The advantage of using the
entire expectorate is that the technique is quicker
to perform, but there are some disadvantages that
require consideration. The expectorate contains a
variable mixture of sputum plus saliva which may
dilute the sputum and confound its analysis. The
reproducibility of cell counts has been reported to be
lower if squamous cell contamination represents
w20% of all recovered cells [4]. There is conflicting
data as to whether or not differential cell counts
(DCCs) differ between the two methods. One study
reported a higher percentage of eosinophils in sputum
processed by the selection method compared to the
entire expectorate [9] but this has not been confirmed
in other studies [2, 6, 10]. Although, both the selected
sputum and the entire expectorate methods have the
same ability to distinguish asthmatics or bronchitics
from healthy subjects, they are not interchangeable,
and, once a technique has been adopted for a given
study, it should always be applied.
When evaluating the most appropriate method
for processing sputum for cellular analysis, a num-
ber of issues need to be considered: 1) sputum sam-
ple homogenisation; 2) duration and temperature of
homogenisation; 3) volume and concentration of
added mucolytic; 4) sample filtration; 5) TCC and
viability; 6) centrifugation and storage of supernatant;
7) cytospin centrifugation, staining and counting; 8)
metachromatic cell staining and counting; 9) slide
reading quality control; 10) immunocytochemical
staining; and 11) in situ hybridisation. Figure 1 is
representative of the two methods of processing to
yield accurate cell counts.
Sputum sample homogenisation
It is recommended that sputum be processed as
soon as possible or within 2 h in order to ensure
optimum cell counting and staining [2, 5]. Complete
homogenisation is important and can be achieved by
the use of dithiothreitol (DTT) and dithioerythritol
to break the disulphide bonds in mucin molecules,
allowing cells to be released [11]. Cells that are incom-
pletely released from mucus tend to stain darkly,
making correct identification difficult. DTT (0.1%),
commonly known as 10% sputalysin solution, has been
shown to be more effective at dispersing cells than
phosphate-buffered saline (PBS), and has no adverse
affects on cell counts. Although some fluid-phase
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indices such as interleukin-5 and -8 and fibrinogen
concentrations remain unaffected, levels of eosinophil
cationic protein and immunoglobulin A are increased
when DTT or dithioerythritol are used [12, 13]. The
effect of the dispersing agent in use should be tested
for each marker of interest (see article entitled
"Analysis of fluid-phase mediators" [14] for more
detail).
Duration and temperature of homogenisation
The duration and temperature of homogenisation
vary between investigators, time ranging 10–30 min
and temperature 4–37uC. It has been demonstrated
that different exposure times to DTT at room
temperature have no effect on the DCC [15]. A
recent study comparing the effect of processing at
room temperature and 37uC on the cellular and fluid
composition of sputum has shown no significant
differences [12]. This indicates that processing at
37uC, which requires a water bath, may be of no
additional benefit. Homogenisation is possible by
using either a shaking water bath at 37uC (and
removing the sample periodically for brief aspiration)
or a tube rocker at 22uC [5, 9, 12]. Few researchers
advocate the use of aspiration and expulsion of
sputum with a plastic transfer pipette as this has
been proven to decrease cell yield due to incomplete
homogenisation [15, 16].
Fig. 1. – Sputum processing method for: a) entire sputum; and b) selected sputum. DTE: dithioerythritol; DTT: dithiothreitol; TCC: total
cell count; DCC: differential cell count. #: see appendix.
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Volume and concentration of added mucolytic
The volume of mucolytic used during processing of
entire expectorate, although fixed at 1:1, is variable in
relation to the ratio of sputum to saliva, which is
unknown [5, 6]. The volume used in the selected
sputum method is fixed.
Sample filtration
Filtration through a 48-mm nylon mesh is com-
monly used to remove mucus and debris, and is
strongly recommended. A single filtration step results
in a slight reduction in the TCC. However, slide
quality is improved and the DCC remains unchanged
[3, 17]. To date, little is known about the effect of
multiple mesh filtrations on the TCC and DCC and
this needs further investigation.
Total cell count and viability
The TCC is performed manually using a haemo-
cytometer, and cell viability is determined by the
trypan blue exclusion method by most investigators
[5, 18]. One important difference is that some per-
form the TCC before centrifugation and others after
centrifugation. A reduction after centrifugation has
been shown by RERECICH et al. [19] and more recently
by EFTHIMIADIS et al. [20], who compared sputum cell
counts and found a 38% reduction in cell yield after
centrifugation. It is, therefore, recommended that the
TCC be performed before centrifugation in order to
facilitate standardisation of this measurement and
to allow meaningful comparisons of counts between
centres and studies. Automated methods for deter-
mining TCC and DCC have been investigated and
found unreliable [15, 16]. Automation is an important
consideration for the evolution of the method, but is
not recommended at present.
Centrifugation and storage of supernatant
Centrifugation is necessary to separate sputum cells
from the fluid phase. The centrifugal force used to
date has ranged 300–1,5006g and the duration of
centrifugation 5–10 min. This appears adequate for
the purpose of separating cells from the superna-
tant [5, 12, 18]; however, the effect on fluid-phase
measurements needs further investigation. The storage
temperature used has ranged -20–-70uC [18]. Further
investigation is required to determine the optimum
storage temperature, which may vary for the different
fluid phase measurements (see article entitled "Analy-
sis of fluid-phase mediators" [14] for more details).
Cytospin centrifugation, staining and counts
Preparation of cytospins with an optimum number
of cells (40–606103 cells) provides a more accurate
estimate of cell distribution than smears [15, 18].
Cytocentrifugation speeds range 10–516g (using a
cytocentrifuge obtained from Shandon Southern
Instruments, Sewickley, PA, USA), with the most
common conditions being 226g for 6 min [15, 18].
Although all are within the limits for minimal cell
distortion, there is a risk of losing lymphocytes at
lower speeds [21, 22]. This should be taken into con-
sideration in investigations of sputum lymphocytes.
Cytospin staining for DCCs can be achieved using
either Wright9s or Giemsa stain. Care should be taken
to ensure that buffers are at the appropriate pH
(7.1–7.2) and that stains are prepared according to
manufacturers9 recommendations for optimum results.
This allows accurate characterisation of cells on the
basis of their staining and morphology. The DCC is
determined by counting a minimum of 400 nonsqua-
mous cells and is reported as the relative numbers of
eosinophils, neutrophils, macrophages, lymphocytes
and bronchial epithelial cells, expressed as a percentage
of total nonsquamous cells. The percentage of squa-
mous cells should always be reported separately.
Metachromatic cell staining and counts
Historically, metachromatic staining, which identi-
fies both basophils and mast cells, has been performed
by means of toluidine blue staining [5, 9, 15, 18].
Although meaningful results have been obtained, one
of the difficulties with this method is obtaining
optimum staining intensity. Cells are often quite
pale, which makes cell identification and enumeration
difficult. This phenomenon appears to be specimen-
dependent and can be resolved by increasing the
staining time from 10 to 60 min. A recent study by
GAVREAU et al. [23] identified the possibility of dis-
criminating between basophils and mast cells using
immunocytochemical techniques. Basophils can be
identified with the 2D7 antibody, which immu-
nolocalises specifially to human basophil secretory
granules. Mast cells can, conversely, be identified with
an alkaline phosphatase-conjugated antitryptase anti-
body that binds specifically to tryptase, a protease
found almost exclusively in mast cells. This would be
the method of choice in studies in which differentia-
tion between basophils and mast cells is relevant.
Slide reading quality control
Every laboratory requires an adequate quality
control programme as an intergral part of standard
operating procedure protocols. This is particularly
important when slide readings are used to monitor
patient medication. Incorrect results can lead to
incorrect diagnosis, treatment and research direction.
First and foremost, it is mandatory that staff are both
qualified and fully trained to avoid legal implications
should problems arise. Monthly quality control
should include internal slide reading as well as
equipment calibration; unless a certain standard of
performance is realised, "normal values" have no
significance.
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Immunocytochemical staining
The sputum cell suspension is centrifuged at 3006g
for 10 min, and the pellet resuspended in PBS.
Cytospins are prepared on polylysine-coated slides
to ensure minimum loss of cells during multiple
washing steps. They are dried in air for 10 min and
fixed appropriately. SHI et al. [24] have shown that
some antigens are cross-linked by paraformaldehyde
and require antigen-retrieval before they can be
recognised by the relevant antibody. Thus the
method of fixation is critical and needs to be deter-
mined as being optimal for the antigen in question.
Some commonly used fixatives are 2 or 4% parafor-
maldehyde, formalin, acetone/methanol (60/40) and
periodate/lysine/paraformaldehyde. The latter is a
fixative for glycoprotein surface staining, but may
also be used for cytokines [25]. After fixation,
cytospins should be wrapped in foil and stored at
-20uC pending staining. Immunocytochemical staining
can be performed using various protocols, including
avidin/biotin complex, peroxidase/antiperoxidase and
alkaline phosphatase/antialkaline phosphatase tech-
niques [23, 26, 27]. The alkaline phosphatase/anti-
alkaline phosphatase method is recommended and
involves application of monoclonal antibodies on
fixed slides at appropriate concentrations and incuba-
tion overnight at 4uC. Secondary antibodies are then
applied and the antibody/antigen complex is visualised
using the alkaline phosphatase-linked substrate, with
either fast red or fast blue counterstains. Negative
controls must always be included to facilitate exclu-
sion of possible false positives due to nonspecific
staining. Peroxidase staining methods are not reccom-
mended for sputum.
In situ hybridisation
Collection of sputum for in situ hybridisation is as
described for immunostaining. In addition, the use of
sterile containers and solutions is crucial in order to
avoid ribonuclease contamination. Cytospins should
be prepared on polylysine-coated slides to reduce cell
loss. Fixation is conducted in 4% paraformaldehyde
for 30 min followed by two washes in PBS for 5 min.
Following fixation, preparations are dried at 37uC and
used immediately or stored at -80uC for later pro-
cessing. For detection of messenger ribonucleic acid
(RNA), a sterile environment is essential. Prepara-
tions should be handled with gloves and all materials
and solutions should be sterile. Although both radio-
active and nonradioactive deoxyribonucleic acid
(DNA) or RNA probes can be used, radiolabelled
complementary RNA is recommended to ensure high
specificity and sensitivity. These probes are usually
generated from complementary DNA and do not
exceed 200–300 base pairs. Hybridisation can be
performed according to standard protocols [28].
Following hybridisation, slides should be washed
under high-stringency conditions and the hybridisa-
tion signal visualised using autoradiography. As for
immunocytochemistry, negative controls should always
be used, including the use of sense probes and
ribonuclease pretreatment.
Key points
It is important to: 1) ensure complete homogeni-
sation of sputum; 2) filter the sputum to remove excess
mucus and debris; 3) perform a manual TCC prior to
centrifugation; 4) count the entire volume of the
counting chamber; 5) prepare cytopsins with an
optimum number of cells; 6) ensure that buffers and
stains are optimised; 7) perform a 400-nonsquamous
cell DCC; 8) report the squamous cells separately; 9)
include positive and negative controls with special
stains; 10) implement a regular quality control system;
and 11) use standard operating procedures.
Outstanding questions
Research questions that still need addressing
include the following. 1) What is the lowest acceptable
cell viability for reliable cell counts? 2) What is the
effect of time lapse to processing sputum on cells and
fluid-phase measurements? 3) What is the influence
of rocking versus standing on the bench on cells
and fluid-phase measurements? 4) What is the effect
of centrifugation rates on cell morphology and
fluid-phase markers? 5) What is the effect of mul-
tiple mesh filtration on cell counts and fluid-phase
measurements?
Appendix: sputum processing methods
Sputalysin working solution
Mix 0.1 mL 10% sputalysin and 0.9 mL distilled
water. Prepare fresh daily.
Processing temperature
Processing at 22uC (room temperature) is adequate
for cell counts. To date, this temperature has been
used for the selected sputum method. Processing at
37uC does not provide any additional benefit. The
effect of temperature on subsequent fluid-phase
measurements needs to be considered in advance.
Total cell count and viability
Mix 10 mL trypan blue and 10 mL sputum cell
suspension. Flood Neubauer haemocytometer count-
ing chamber. Count the entire area (9 mm2). Report
cell viability as a percentage. A cell viability ofv40%
may affect the DCC.
Cytospin preparation
Adjust cell concentration to 1.06106 cells?mL-1.
Add 40–65 mL sample (or 450–6506103 cells) to each
cytospin.
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Differential cell counting
Stain with Wright9s or Giemsa stain. Count 400
nonsquamous cells. Report proportions of neutro-
phils, eosinophils, macrophages, lymphocytes and
bronchial epithelial cells relative to total nonsqua-
mous cell count. Report proportion of squamous cell
contamination separately.
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